Health

Medikine

Private Company

Medikine utilizes a proprietary platform to identify agonists of clinically relevant heterodimeric cytokine receptors for the development of novel therapeutics for immuno-oncology applications in cell therapy and neo-antigen vaccines.

medikine.com

U.S.

Therapeutics

Leaders
Ronald W. Barrett, Ph.D.

CEO

William J. Dower, Ph.D.

Founder & CSO

Michael C. Needels, Ph.D.

Founder & COO

Lightspeed Team
Jonathan MacQuitty

Venture Partner

Medikine utilizes a proprietary platform to identify agonists of clinically relevant heterodimeric cytokine receptors for the development of novel therapeutics for immuno-oncology applications in cell therapy and neo-antigen vaccines.